Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction
Dylan M Buller,1,* Maria Antony,2,* Benjamin T Ristau1 1Division of Urology, UConn Health, Farmington, CT, USA; 2University of Connecticut School of Medicine, Farmington, CT, USA*These authors contributed equally to this workCorrespondence: Benjamin T Ristau, Division of Urol...
Main Authors: | Buller DM, Antony M, Ristau BT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/adjuvant-therapy-for-high-risk-localized-renal-cell-carcinoma-current--peer-reviewed-fulltext-article-OTT |
Similar Items
-
The emerging landscape of neo/adjuvant immunotherapy in renal cell carcinoma
by: Pooya Dibajnia, et al.
Published: (2023-01-01) -
Systemic adjuvant therapies in renal cell carcinoma
by: Sebastiano Buti, et al.
Published: (2012-10-01) -
Front-Line Therapy for Metastatic Renal Cell Carcinoma: A Perspective on the Current Algorithm and Future Directions
by: Ameish Govindarajan, et al.
Published: (2022-04-01) -
Adjuvant therapy for renal cell carcinoma, finally a new standard?
by: Alex Renner, et al.
Published: (2022-09-01) -
Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?
by: Federica Cosso, et al.
Published: (2023-02-01)